(Q43564034)

24 November 2017

title

Short-term dosing of alpha-hydroxytamoxifen results in DNA damage but does not lead to liver tumours in female Wistar/Han rats (English)

1 reference

24 November 2017

0 references

White IN

1

1 reference

24 November 2017

Carthew P

2

1 reference

24 November 2017

Davies R

3

1 reference

24 November 2017

Styles J

4

1 reference

24 November 2017

Brown K

5

1 reference

24 November 2017

Brown JE

6

1 reference

24 November 2017

Smith LL

7

1 reference

24 November 2017

Martin EA

8

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

24 November 2017

1 reference

24 November 2017

volume

22

1 reference

24 November 2017

issue

4

1 reference

24 November 2017

page(s)

553-557

1 reference

Tamoxifen--the treatment of choice. Why look for alternatives?

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F22.4.553

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F22.4.553

DNA damage as assessed by 32P-postlabelling in three rat strains exposed to dietary tamoxifen: the relationship between cell proliferation and liver tumour formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F22.4.553

21 January 2018

The tamoxifen dilemma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F22.4.553

A mechanistic hypothesis for DNA adduct formation by tamoxifen following hepatic oxidative metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F22.4.553

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F22.4.553

Tamoxifen-DNA adducts detected in the endometrium of women treated with tamoxifen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F22.4.553

Evaluation of tamoxifen and alpha-hydroxytamoxifen 32P-post-labelled DNA adducts by the development of a novel automated on-line solid-phase extraction HPLC method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F22.4.553

Separate roles of androgen and oestrogen in the manipulation of growth and efficiency of food utilization in female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F22.4.553

Comparison of the effects of tamoxifen and toremifene on liver and kidney tumor promotion in female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F22.4.553

Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F22.4.553

Tumor promotion as a target for estrogen/antiestrogen effects in rat hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F22.4.553

A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F22.4.553

Identification of the major tamoxifen-DNA adducts in rat liver by mass spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F22.4.553

DNA adducts of chemical carcinogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F22.4.553

21 January 2018

Identifiers

DOI

10.1093/CARCIN/22.4.553

1 reference

24 November 2017

1 reference